Brooks Laboratories Limited has fixed the price band for its upcoming IPO at Rs.90/- to Rs.100/- per equity share. Brooks Laboratories Ltd is in the business of Pharmaceutical Contract Research & Manufacturing. Company manufactures wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc.
Brooks Laboratories Limited IPO would remain open for subscription between August 16, 2011 and August 18, 2011. D and A Financial Services Pvt. Ltd. is the Book Running Lead Manager of the IPO, while Link Intime India Pvt. Ltd. is the Registrar to the IPO
Check back Indian IPO Blog for further updates on Brooks Laboratories Limited IPO!
Share this post on: Facebook or
Email this post to a Friend:
Posts
0 Comments:
Post a Comment